Hamilton Thorne (TSX:HTL) Debt-to-Equity : 0.43 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Debt-to-Equity?

Hamilton Thorne's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$8.09 Mil. Hamilton Thorne's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$28.62 Mil. Hamilton Thorne's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$85.86 Mil. Hamilton Thorne's debt to equity for the quarter that ended in Mar. 2024 was 0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hamilton Thorne's Debt-to-Equity or its related term are showing as below:

TSX:HTL' s Debt-to-Equity Range Over the Past 10 Years
Min: -41.4 Med: 0.33 Max: 21.28
Current: 0.43

During the past 13 years, the highest Debt-to-Equity Ratio of Hamilton Thorne was 21.28. The lowest was -41.40. And the median was 0.33.

TSX:HTL's Debt-to-Equity is ranked worse than
68.27% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs TSX:HTL: 0.43

Hamilton Thorne Debt-to-Equity Historical Data

The historical data trend for Hamilton Thorne's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Debt-to-Equity Chart

Hamilton Thorne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.31

0.20

0.17

0.32

0.43

Hamilton Thorne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.31	0.34	0.39	0.43	0.43

Competitive Comparison of Hamilton Thorne's Debt-to-Equity

For the Medical Devices subindustry, Hamilton Thorne's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hamilton Thorne's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's Debt-to-Equity falls into.

Hamilton Thorne Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hamilton Thorne's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(7.909	+	29.594)	/	86.736
	=	0.43

Hamilton Thorne's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.088	+	28.615)	/	85.86
	=	0.43

Hamilton Thorne (TSX:HTL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Hamilton Thorne Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamilton Thorne (TSX:HTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

HTLZF:USA 0ZM:Germany

Address

100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915

Website

https://www.hamiltonthorne.ltd

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Executives

Robert J Potter

Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines